WAM
PGNX

Wealthspire Advisors (Maryland)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17
Closed – – 2667
2017
Q3 		$0 Buy
+17
New – ﹤0.01% 2571